Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Hummingbird Bioscience to Present Two Posters on Anti-HER3 and Anti-VISTA Antibody Therapeutics at American Association for Cancer Research (AACR) Meeting 2024 2024-03-06 05:30
Zymo Research Pioneers a Breakthrough in Large-scale Animal-free RNase A Production 2024-03-05 22:00
YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries 2024-03-05 21:00
Angel Yeast Hosts Webinar with PPTI to Promote Sustainable Development of Proteins 2024-03-05 21:00
WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment 2024-03-05 21:00
IRBM Expands Global Reach in Drug Discovery with New Boston Office 2024-03-05 20:24
First Patient Treated in Phase 2 GvHD Trial 2024-03-05 10:08
Henlius Forecasts Profit in 2023: Achieving first full year of profitability, and ushering in a new phase of high-quality development 2024-03-04 21:19
Landmark Clinical Approval for YOLT-201 Obtained by the NMPA 2024-03-04 20:00
Hybribio Calls for Raising International HPV Awareness 2024-03-04 18:47
Results from the Clinical Trial of Qilu Pharmaceutical's Novel Anticancer Agent Iparomlimab and Tuvonralimab (QL1706) Featured in Oral Presentation at the ESGO Annual Meeting 2024-03-04 16:53
NMPA Approves the NDA for CARsgen's BCMA CAR-T Therapy Zevorcabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma 2024-03-01 21:50
Thermo Fisher Scientific to Inaugurate New Office, Marking Milestone Expansion in Indonesia 2024-03-01 10:30
Innovent Announces First Participant Dosed in a Phase I Study of IBI3002 (an anti-IL-4Rα/TSLP bispecific antibody) in Australia 2024-03-01 08:00
Metabolon Unveils New Integrated Bioinformatics Platform 2024-02-29 20:58
Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency 2024-02-29 17:40
MGI Tech & Juntendo University: Changing the Landscape and Unlocking Answers for Patients with Rare Diseases 2024-02-29 09:00
Skyhawk Therapeutics Has Advanced to the Multiple Ascending Dose Portion of its Phase 1 Study evaluating SKY-0515, a RNA-Targeting Small Molecule for Huntington's Disease 2024-02-28 21:32
RRD International is now RRD Biopharma Development 2024-02-28 21:00
PharmAust announces positive Phase 1 MEND Study Top-Line Results in MND / ALS 2024-02-28 20:47
1 12 13 14 15 16 414